As of May 24
| 0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for ANI Pharmaceuticals Inc have a median target of 75.50, with a high estimate of 82.00 and a low estimate of 69.00. The median estimate represents a +19.96% increase from the last price of 62.94.
The current consensus among 2 polled investment analysts is to Buy stock in ANI Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.